Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial
2005

Intensive Insulin Therapy and Inflammation in Heart Surgery Patients

Sample size: 20 publication Evidence: moderate

Author Information

Author(s): Hoedemaekers Cornelia W, Pickkers Peter, Netea Mihai G, van Deuren Marcel, Van der Hoeven Johannes G

Primary Institution: Radboud University Nijmegen Medical Centre

Hypothesis

Strict glucose regulation results in a change in cytokine balance from a pro-inflammatory state to a more balanced anti-inflammatory condition.

Conclusion

Intensive insulin therapy does not change the inflammatory response in patients after cardiac surgery.

Supporting Evidence

  • Both patient groups were comparable in demographics and clinical characteristics.
  • Glucose levels were significantly lower in the intensive treatment group.
  • No differences were found in cytokine concentrations between the treatment groups.
  • IL-6 and IL-10 levels were significantly higher in mediastinal fluid than in plasma samples.

Takeaway

This study found that giving insulin to control blood sugar levels after heart surgery doesn't change the levels of certain inflammatory substances in the body.

Methodology

Patients were randomly assigned to intensive or conventional insulin therapy, and cytokine levels were measured at various time points after surgery.

Limitations

The study only included non-diabetic patients and may not be generalizable to all cardiac surgery patients.

Participant Demographics

Non-diabetic patients undergoing elective coronary artery bypass grafting.

Statistical Information

P-Value

p<0.003

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc3911

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication